Clinical Director Parkinson's Foundation Centre of Excellence, King's College Hospital, London, United Kingdom; Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, United Kingdom.
Department of Neurology, Neurosurgery and Medical Genetics, Federal State Autonomous Educational Institution of Higher Education "N.I. Pirogov Russian National Research Medical University" of the Ministry of Health of the Russian Federation, Moscow, Russia; Department of Neurodegenerative Diseases, Federal State Budgetary Institution 'Federal Center of Brain and Neurotechnologies' of the Ministry of Health of the Russian Federation, Moscow, Russia.
Int Rev Neurobiol. 2022;162:21-34. doi: 10.1016/bs.irn.2022.01.001. Epub 2022 Feb 25.
Sexual dysfunction is a common, poorly recognized, poorly discussed (often because of cultural perceptions and sensitivities), bothersome and neglected aspect of the range of non-motor symptoms of Parkinson's disease (PD). The spectrum of sexual dysfunction in PD ranges from hyposexuality-based disturbances to hypersexuality-dominated behaviors in the context of drug-induced impulse control disorder. The pathophysiological mechanisms underlying PD-related sexual dysfunction, specifically for hyposexual disorders, are thus heterogeneous and still not fully understood. However, central and peripheral neural mechanisms secondary to the hallmark pathological alterations of the disease (alpha-synuclein deposition and nigrostriatal degeneration) and to the associated network and neurotransmitter dysfunctions, together with the effects of dopaminergic therapies, seem to play an important role in the development of sexual disturbances. In this chapter, we therefore review the neuroanatomical and neurophysiological basis of sexual function in humans, and we provide insights on the pathophysiological mechanisms of hyposexuality and hypersexuality in PD.
性功能障碍是帕金森病(PD)一系列非运动症状中常见但未被充分认识、讨论不足(通常由于文化观念和敏感性所致)、令人困扰且被忽视的方面。PD 相关性功能障碍的范围从基于性欲减退的障碍到药物诱导的冲动控制障碍背景下以性欲亢进为主的行为。PD 相关性功能障碍的病理生理机制,特别是性欲减退障碍的机制,因此具有异质性,仍不完全清楚。然而,继发于疾病标志性病理改变(α-突触核蛋白沉积和黑质纹状体变性)以及相关网络和神经递质功能障碍的中枢和外周神经机制,加上多巴胺能治疗的影响,似乎在性功能障碍的发展中发挥重要作用。因此,在本章中,我们回顾了人类性功能的神经解剖学和神经生理学基础,并深入探讨了 PD 中性欲减退和性欲亢进的病理生理机制。